chlorzoxazone
- Product NDC
- 68462-725
- 11-digit product format
- 684620725
- Labeler code
- 68462
- Product ID
- 68462-725_31777bf1-9074-4232-b32f-3e675a68f51d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- chlorzoxazone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Application
- ANDA212185
- Marketing category
- ANDA
- Marketing start
- 2020-05-26
- Marketing end
- 2022-09-01
- Substance
- CHLORZOXAZONE
- Active strength
- 750 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68462-725-01 | 68462072501 | 100 TABLET in 1 BOTTLE, PLASTIC (68462-725-01) | 100 tablet | 2020-05-26 | 0000-00-00 | No | No | Current |
| 68462-725-05 | 68462072505 | 500 TABLET in 1 BOTTLE, PLASTIC (68462-725-05) | 500 tablet | 2020-05-26 | 0000-00-00 | No | No | Current |